So in May 2021 I tried to get LL introduced to NIH and NIAD through my UCLA infectious diseases expert friend and I got the same questioning as Dr. JL from that guy Murphy who was saying why is he not looking at the good work Giliead and Pfizer are doing. Here's what my friend wrote back at that time:

" I will send your email to colleagues at NIAID to see who might be in the loop.
BTW, why is this monoclonal therapy trial of interest to you?"

I got the impression that the NIH was a closed incestuous friendship group and we at CYDY didn't belong for a whole variety of reasons.